Billiontoone (NASDAQ:BLLN) SVP Bosch John Roderick Ten Sells 2,834 Shares of Stock

Billiontoone, Inc. (NASDAQ:BLLN) SVP Bosch John Roderick Ten sold 2,834 shares of the firm’s stock in a transaction on Monday, November 2nd. The stock was sold at an average price of $113.17, for a total value of $320,723.78. Following the completion of the transaction, the senior vice president owned 16,551 shares in the company, valued at $1,873,076.67. The trade was a 14.62% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bosch John Roderick Ten also recently made the following trade(s):

• On Monday, October 5th, Bosch John Roderick Ten sold 2,834 shares of Billiontoone stock. The stock was sold at an average price of $105.15, for a total transaction of $297,995.10.
• On Thursday, September 24th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The stock was sold at an average price of $120.00, for a total transaction of $169,920.00.
• On Monday, September 21st, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $106.61, for a total transaction of $150,959.76.
• On Wednesday, September 9th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $97.54, for a total transaction of $138,116.64.
• On Tuesday, August 25th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $100.00, for a total transaction of $141,700.00.
• On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The shares were sold at an average price of $92.86, for a total transaction of $131,582.62.

Billiontoone Stock Up 3.1%

NASDAQ BLLN opened at $113.89 on Thursday. The business has a fifty day moving average price of $104.67 and a two-hundred day moving average price of $96.89. The stock has a market capitalization of $5.37 billion and a PE ratio of 162.70. Billiontoone, Inc. has a fifty-two week low of $61.96 and a fifty-two week high of $150.44. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31.

Billiontoone (NASDAQ:BLLN) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, hitting the consensus estimate of $0.15. The business had revenue of $109.45 million during the quarter. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%. Equities analysts expect that Billiontoone, Inc. will post 0.80 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. BTIG Research cut their target price on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a research report on Thursday, August 6th. Weiss Ratings cut Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a research note on Thursday, October 8th. Wall Street Zen cut Billiontoone from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. JPMorgan Chase & Co. dropped their target price on Billiontoone from $145.00 to $130.00 and set an “overweight” rating for the company in a research report on Thursday, August 6th. Finally, Canaccord Genuity Group initiated coverage on Billiontoone in a research note on Wednesday, September 2nd. They set a “buy” rating and a $120.00 price target on the stock. Seven analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Billiontoone has an average rating of “Moderate Buy” and a consensus target price of $126.25.

Trending Headlines about Billiontoone

Here are the key news stories impacting Billiontoone this week:

• Positive Sentiment: Q3 results topped expectations: Revenue was about $123.0 million, above the $115.8 million FactSet estimate. Reported earnings per share also exceeded the $0.16 consensus, although sources cite different actual EPS figures ($0.32 and $0.48). BillionToOne Q3 results and guidance
• Positive Sentiment: Higher 2026 revenue guidance: The company raised its full-year revenue outlook, signaling improved expectations for growth. Company announcement
• Negative Sentiment: Multiple insiders sold shares: The CEO, CTO and an SVP reported sales. The transactions were made under pre-arranged Rule 10b5-1 plans, which may temper—but do not eliminate—the bearish signal investors could take from insider selling. Insider transaction reports

Hedge Funds Weigh In On Billiontoone

A number of hedge funds have recently modified their holdings of the business. Integrated Wealth Concepts LLC acquired a new stake in Billiontoone in the second quarter valued at $29,000. Parallel Advisors LLC lifted its holdings in Billiontoone by 86.7% during the 3rd quarter. Parallel Advisors LLC now owns 280 shares of the company’s stock worth $30,000 after buying an additional 130 shares during the period. Family Legacy Financial Solutions LLC acquired a new position in Billiontoone during the 3rd quarter worth about $53,000. MCF Advisors LLC grew its position in shares of Billiontoone by 330.8% in the 2nd quarter. MCF Advisors LLC now owns 448 shares of the company’s stock valued at $54,000 after buying an additional 344 shares during the last quarter. Finally, Provenance Wealth Advisors LLC bought a new stake in shares of Billiontoone in the 3rd quarter valued at about $56,000.

About Billiontoone

BillionToOne, Inc is a molecular diagnostics company that develops tests designed to provide more sensitive and quantitative genetic information from blood samples. The company’s technology is based on its proprietary Quantitative Counting Template (QCT) platform, which is designed to measure DNA molecules with high sensitivity and support the detection of clinically meaningful genetic signals.

The company’s products include prenatal diagnostic and screening solutions marketed under the UNITY brand.